Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life science and diagnostic industries. The company’s open-architecture xMAP® Technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.
Systems using xMAP Technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.
Luminex Vision Statement
Worldwide Leader in Multiplexed Solutions
Specialties
Molecular Diagnostics, xMAP Technology, Life Science Research, Multiplexing
New hires at Luminex Corporation
-
-
Director, Life Science Research Partner Operations
Came from...
Illumina, Business Development Manager
-
Extramural Research Manager
Came from...
Texas Department of State Health Services, Emergency Preparedness Branch Manager
-
Luminex Corporation Activity on LinkedIn
-
Luminex Corporation has a new Laboratory Technologist
Jennifer Wolken is now Laboratory Technologist, was Scientific and Technical Sales at Kimberly-Clark
-
